PDS Biotechnology Corporation (PDSB)
USD 1.81
(-7.91%)
USD 1.81
(-7.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 57.32 Thousand | 49.07 Thousand | 246.38 Thousand | 176.29 Thousand | 98.41 Thousand | 69.11 Thousand |
| Gross Profit | -57.32 Thousand | -49.07 Thousand | -246.38 Thousand | -176.29 Thousand | -98.41 Thousand | -69.11 Thousand |
| Operating Expenses | 43.04 Million | 41.67 Million | 21.43 Million | 14.9 Million | 17.08 Million | 30.35 Million |
| Selling, General and Administrative Expenses | 15.28 Million | 12.24 Million | 10.18 Million | 6.96 Million | 10.98 Million | 14.29 Million |
| Research and Development Expenses | 27.76 Million | 29.43 Million | 11.25 Million | 7.92 Million | 6.09 Million | 16.06 Million |
| Other Expenses | - | - | - | 15.6 Thousand | 3.95 Billion | 12.73 Billion |
| Cost and Expenses | 43.04 Million | 41.67 Million | 21.43 Million | 14.9 Million | 17.08 Million | 30.35 Million |
| Operating Income | -43.04 Million | -41.67 Million | -21.43 Million | -14.9 Million | -21.03 Million | -43.09 Million |
| Interest Expense | 4.2 Million | 1.31 Million | - | - | 33.55 Thousand | 1.42 Million |
| Income Tax Expense | -1.4 Million | -1.19 Million | -4.51 Million | -135.68 Thousand | -381.51 Thousand | -2.78 Million |
| Earnings before Tax | -44.34 Million | -42.05 Million | -21.43 Million | -14.84 Million | -7.38 Million | -43.64 Million |
| Net Income | -42.94 Million | -40.85 Million | -16.91 Million | -14.84 Million | -6.99 Million | -40.86 Million |
| Earnings Per Share Basic | -1.39 | -1.43 | -0.66 | -0.89 | -1.44 | -26.16 |
| Earnings Per Share Diluted | -1.39 | -1.43 | -0.66 | -0.89 | -1.44 | -26.16 |
| Weighted Average Shares Outstanding | 30.95 Million | 28.59 Million | 25.59 Million | 16.74 Million | 4.86 Million | 1.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.95 Million | 28.59 Million | 25.59 Million | 16.74 Million | 4.86 Million | 1.56 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -40.08 Million | -41.62 Million | -21.18 Million | -14.67 Million | -7.24 Million | -3.57 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 15.12 Thousand | 14.4 Thousand | 14.4 Thousand | 57.32 Thousand | 14.4 Thousand | 74.66 Thousand |
| Gross Profit | -15.12 Thousand | -14.4 Thousand | -14.4 Thousand | -57.32 Thousand | -14.4 Thousand | -74.66 Thousand |
| Operating Expenses | 8.66 Million | 10.08 Million | 10.39 Million | 42.98 Million | 10.51 Million | 12.69 Million |
| Selling, General and Administrative Expenses | 4.14 Million | 3.37 Million | 2.92 Million | - | 4.07 Million | 4.69 Million |
| Research and Development Expenses | 4.52 Million | 6.7 Million | 7.46 Million | - | 6.44 Million | 8 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 8.68 Million | 10.09 Million | 10.4 Million | 43.04 Million | 10.51 Million | 12.69 Million |
| Operating Income | -8.68 Million | -10.09 Million | -10.4 Million | -43.04 Million | -10.51 Million | -12.69 Million |
| Interest Expense | 1.18 Million | 1.17 Million | 1.17 Million | 4.2 Million | -1.06 Million | 995.39 Thousand |
| Income Tax Expense | -869.16 Thousand | 5.00 | 2.00 | -1.4 Million | -4733.00 | -1.4 Million |
| Earnings before Tax | -9.19 Million | -10.6 Million | -10.89 Million | -44.34 Million | -10.84 Million | -12.94 Million |
| Net Income | -8.32 Million | -10.6 Million | -10.89 Million | -42.94 Million | -10.84 Million | -11.53 Million |
| Earnings Per Share Basic | -0.23 | -0.30 | -0.34 | - | -0.35 | -0.37 |
| Earnings Per Share Diluted | -0.23 | -0.30 | -0.34 | - | -0.35 | -0.37 |
| Weighted Average Shares Outstanding | 36.69 Million | 34.81 Million | 31.66 Million | 30.95 Million | 30.91 Million | 30.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.69 Million | 34.81 Million | 31.66 Million | 30.95 Million | 30.91 Million | 30.8 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -8.66 Million | -10.08 Million | -10.39 Million | - | -10.51 Million | -11.94 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ZEN
4770
2715
CNX
DNOW
LTSK